CN110028562B - Optimized Komagataella pastoris yeast alpha-factor signal peptide and application - Google Patents

Optimized Komagataella pastoris yeast alpha-factor signal peptide and application Download PDF

Info

Publication number
CN110028562B
CN110028562B CN201910338973.9A CN201910338973A CN110028562B CN 110028562 B CN110028562 B CN 110028562B CN 201910338973 A CN201910338973 A CN 201910338973A CN 110028562 B CN110028562 B CN 110028562B
Authority
CN
China
Prior art keywords
signal peptide
factor signal
alpha
optimized
komagataella pastoris
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910338973.9A
Other languages
Chinese (zh)
Other versions
CN110028562A (en
Inventor
黄义德
吴静雯
洪文柄
林尧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuzhou Liangyan Technology Co ltd
Original Assignee
Fuzhou Liangyan Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuzhou Liangyan Technology Co ltd filed Critical Fuzhou Liangyan Technology Co ltd
Priority to CN201910338973.9A priority Critical patent/CN110028562B/en
Publication of CN110028562A publication Critical patent/CN110028562A/en
Application granted granted Critical
Publication of CN110028562B publication Critical patent/CN110028562B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses an optimized Komagataella pastoris yeast alpha-factor signal peptide and application thereof. The invention introduces an N glycosylation site into the Komagataella pastoris yeast alpha-factor signal peptide with the amino acid sequence shown as SEQID NO. 1 to obtain the optimized Komagataella pastoris yeast alpha-factor signal peptide, and the amino acid sequence of the optimized Komagataella pastoris yeast alpha-factor signal peptide is shown as SEQID NO. 3. The optimized alpha-factor signal peptide is particularly suitable for guiding the secretory expression of the foreign protein in pichia pastoris, compared with the signal peptide before optimization, the expression level is improved by 25-35 times, the application of the optimized alpha-factor signal peptide is favorable for screening high-expression strains, and the optimized alpha-factor signal peptide has the advantages of reducing the production cost, facilitating subsequent purification and the like.

Description

Optimized Komagataella pastoris yeast alpha-factor signal peptide and application
Technical Field
The invention belongs to the technical field of biology, and particularly relates to an optimized Komagataella pastoris yeast alpha-factor signal peptide and application thereof.
Background
In recent years, with the improvement of living standard and the enhancement of health consciousness, the demand of various protein drugs (such as vaccine, immunoglobulin, antibody, protein factor and the like) for treatment or health care has been rising year by year. However, many pharmaceutical proteins cannot be obtained by separation and purification of natural materials, and must be expressed using a foreign protein system.
In the existing foreign protein expression system, although a prokaryotic system has simple genetic operation, low culture cost and high product expression, the foreign protein cannot be subjected to post-translational modification. Eukaryotic systems can perform post-translational processing modification on expressed foreign proteins, so that the obtained products generally have higher biological activity compared with prokaryotic systems. Because the pichia pastoris expression system serving as a unicellular eukaryote has the characteristics of both eukaryote and prokaryote, the pichia pastoris expression system is favored by researchers when researching secretory proteins needing to be processed and modified. Most secreted proteins have important physiological regulatory functions, such as peptide hormones, neuropeptides, insulin and its receptors, growth and differentiation factors, cell surface receptors, extracellular metalloproteinases, blood coagulation factors, adhesion molecules, plasma proteins, etc., of which a considerable proportion are candidates for pharmaceutical proteins or have been successful protein drugs.
When pichia pastoris is used for expressing foreign secretory proteins, a signal peptide is needed to guide the foreign proteins to enter a secretory channel, and finally the proteins can be secreted outside cells. The efficiency of the signal peptide determines the secretory expression of the foreign protein. Therefore, the development of a signal peptide capable of efficiently secreting the protein to the extracellular space in pichia pastoris is important for the secretory expression of the foreign protein.
Disclosure of Invention
The invention aims to provide an optimized Komagataella pastoris alpha-factor signal peptide and application thereof, wherein the optimized signal peptide can efficiently guide secretion of foreign proteins in pichia pastoris
In order to achieve the purpose, the invention adopts the following technical scheme:
firstly, the invention analyzes the genome sequence of Komagataella pastoris, finds an alpha-factor gene, and obtains an alpha-factor gene signal peptide from the alpha-factor gene, wherein the amino acid sequence of the alpha-factor gene signal peptide is shown as SEQIDNO 1, and the nucleotide sequence for coding the alpha-factor gene signal peptide is shown as SEQID NO 2.
The alpha-factor signal peptide can guide the secretory expression of a target protein.
Further, an N glycosylation site is introduced into the amino acid sequence of the alpha-factor signal peptide to obtain the optimized alpha-factor signal peptide, the amino acid sequence of the optimized alpha-factor signal peptide is shown as SEQ ID NO. 3, and the nucleotide sequence for coding the alpha-factor signal peptide is shown as SEQ ID NO. 4.
The N glycosylation sites can be introduced into any position of the Komagataella pastoris yeast alpha-factor signal peptide, and the number of the introduced N glycosylation sites can be 1 or more. In the present invention, the N-glycosylation site is located at amino acid 113.
The optimized alpha-factor signal peptide can efficiently guide the secretion expression of foreign proteins.
The foreign protein can be any protein, and is green fluorescent protein in the invention.
The optimized alpha-factor signal peptide can be added into a Komagataella pastoris intracellular expression vector for guiding the secretory expression of foreign proteins in the Komagataella pastoris.
The intracellular expression vector may be any one of: pGAPA, B & C, pAO815, pPIC3.5K, pPIC3.5, pFLD1 and pPICZA, B & C. In the examples of the present invention, the intracellular expression vector used is pPICZA.
The invention compares the signal peptide of the Komagataella pastoris yeast alpha-factor before and after sequence optimization with the expression of exogenous protein. The expression amount measurement result shows that the optimized alpha-factor signal peptide is particularly suitable for Komagataella pastoris, compared with the signal peptide before optimization, the expression level is improved by 25-35 times, the application of the signal peptide is favorable for screening high-expression strains, and the signal peptide has the advantages of reducing the production cost, facilitating subsequent purification and the like.
Drawings
FIG. 1 is a diagram of the expression of a foreign protein guided by the Komagataella pastoris yeast alpha-factor signal peptide;
FIG. 2 is a comparison graph of the expression level of foreign proteins guided by the Komagataella pastoris yeast α -factor signal peptide before and after optimization.
Detailed Description
The following examples illustrate the invention in detail, but do not limit the scope of the invention.
Before optimization
The amino acid sequence of the Komagataella pastoris yeast alpha-factor signal peptide is shown as SEQ ID NO. 1.
The nucleotide sequence of the nucleotide for coding the optimized Komagataella pastoris yeast alpha-factor signal peptide is shown as SEQ ID NO. 2.
After optimization
The amino acid sequence of the optimized Komagataella pastoris yeast alpha-factor signal peptide is shown as SEQ ID NO. 3.
The nucleotide sequence of the nucleotide for coding the optimized Komagataella pastoris yeast alpha-factor signal peptide is shown as SEQ ID NO. 4.
EXAMPLE 1 Synthesis of the coding sequence for the Yeast alpha-factor Signal peptide of Komagataella pastoris
The coding sequence encoding the Komagataella pastoris yeast α -factor signal peptide was synthesized by bio-corporation and cloned into a T-vector, designated pT- α -factor in this example.
Example 2 construction of a Yeast expression vector containing Komagataella pastoris Yeast alpha-factor Signal peptide Komagataella pastoris
In this example, pPICZA is used as a framework to describe the construction process of a yeast expression vector containing a Komagataella pastoris alpha-factor signal peptide.
The vector pPICZA was digested with Sfu I and EcoR I, and the gel was split and purified for use.
Designing a pair of primers:
an upstream primer: tt is a Chinese characterttcgaaatgaaaccactttataagc (Sfu I site sequence underlined)
A downstream primer: cg (cg)gaattcagcttctgccttctcttgcc (underlined section EcoR I site sequence)
The coding sequence for the Komagataella pastoris yeast α -factor signal peptide was amplified from the vector pT- α -factor and Sfu I and EcoR I cleavage sites were introduced at both ends, respectively. And purifying the PCR amplification product, performing double enzyme digestion by using Sfu I and EcoR I enzymes, and tapping and purifying the gel for later use.
The vector pPICZA after double enzyme digestion of Sfu I and EcoR I is connected with the coding sequence of the Komagataella pastoris alpha-factor signal peptide. The ligation product is transformed into escherichia coli, a single colony growing from a Zeocin plate is selected for sequencing confirmation, and a vector with correct sequence is named as pPICZA K.pa -α-factor。
Example 3 construction of optimized Komagataella pastoris Yeast alpha-factor Signal peptide Komagataella pastoris Yeast expression vector
Through the amino acid sequence analysis of the Komagataella pastoris alpha-factor signal peptide, the serine (S) at the 113 th site of the Komagataella pastoris alpha-factor signal peptide can be changed into an N-glycosyl modified site through point mutation. Thus, a pair of point mutation primers was designed:
an upstream primer: GAGAGGTTCAGTTCAATTGGACACACACATTAGG
A downstream primer: CCTAATGTGTGTCCAATTGAACTGAACTCTCTC
With pPICZA K.pa The alpha-factor vector is used as a framework, serine (S) at the 113 th site of the Komagataella pastoris alpha-factor signal peptide is mutated into asparagine (N) by using a point mutation kit and operating according to the instruction, and the newly constructed recombinant plasmid is named as pPICZA K.pa - S113N - α -factor. The point mutation kit used in this example is Fast Mutagenesis System, a product of Beijing Quanji Biotechnology (TransGen Biotech) Ltd.
Example 4 expression of foreign proteins in Komagataella pastoris using expression vectors containing Komagataella pastoris yeast alpha-factor signal peptide before and after optimization
In the embodiment, enhanced Green Fluorescent Protein (EGFP) is used as a reporter protein to detect the capability of guiding the secretion and expression of foreign proteins by Komagataella pastoris yeast alpha-factor signal peptide before and after optimization.
EGFP fragments were amplified from commercial vector pEGFP-N1 using a pair of specific primers containing EcoR I cleavage sites at the 5' end.
An upstream primer: cg (cg)gaattcatggtgagcaagggcgagag (underlined part is EcoR I site sequence)
A downstream primer: cg (cg)gaattcttactgtacagcctgtccat (EcoR I site sequence in underlined part)
Respectively cloning the EGFP fragments amplified to an expression vector pPICZA by using a DNA recombination technology K.pa -alpha-factor and pPICZA K.pa - S113N At the-alpha-factor EcoR I siteThe vectors are named pPICZA respectively K.pa -alpha-factor-EGFP and pPICZA K.pa - S113N -α-factor-EGFP。
pPICZA K.pa -alpha-factor-EGFP and pPICZA K.pa - S113N Before the-alpha-factor-EGFP vector is used for electrically transforming the Komagataella pastoris yeast, the vector is linearized by Sac I enzyme and purified after linearization.
Adding 100 μ l of freshly prepared competent Komagataella pastoris yeast into 1-10 μ g of linearized vector; transferring into an electric rotating cup (specification of 0.2 mm); a Bio-Rad GenePulser electric conversion instrument is used under the conditions of 1500V,25 muF and 200 omega, 1ml of 1M sorbitol (precooling) is added to the mixture immediately after electric shock, and the mixture is subjected to static culture for 1-2h in an incubator at the temperature of 28-30 ℃. After the culture, 200-400. Mu.l of the culture solution was spread on YPD plates (10 cm) containing Zeocin, and the plates were placed in a constant temperature incubator at 28-30 ℃ for inverted culture.
Selecting a single colony on the YPD plate to be cultured in a constant temperature shaking table of 5ml BMGY,28-30 ℃ and 250r/min for 24h; and (5) observing the growth condition and whether the bacteria are infected or not in the BMGY by microscopic examination. And centrifugally collecting thalli at room temperature of 1500-3000g, re-suspending the thalli by using an induction culture medium BMMY, and adjusting the dosage of the BMMY culture medium to enable the final OD600 value to be about 1.0. Culturing the culture solution in a constant temperature shaking table at 28-30 ℃. Every 24h, methanol (1% of the induction culture volume is added) is added; after methanol induction for 72h, the fermentation supernatant was subjected to Western blot detection using EGFP antibody, and the results are shown in FIG. 2.
FIG. 1 is a diagram showing that a Komagataella pastoris yeast α -factor signal peptide guides the expression of a foreign protein before optimization, and it can be seen that the Komagataella pastoris yeast α -factor signal peptide can guide the secretion of the foreign protein but has a low secretion level.
FIG. 2 is a comparison graph of the expression level of foreign proteins guided by the Komagataella pastoris yeast α -factor signal peptide before and after optimization. The determination result of the expression quantity in figure 2 shows that the optimized alpha-factor signal peptide is particularly suitable for guiding the secretory expression of the foreign protein in the Komagataella pastoris yeast, compared with the signal peptide before optimization, the expression level is improved by more than 25 times, and the application of the optimized alpha-factor signal peptide is favorable for screening high-expression strains and has the advantages of reducing the production cost, facilitating subsequent purification and the like.
Sequence listing
<110> university of Fujian teaching
<120> optimized Komagataella pastoris yeast alpha-factor signal peptide and application
<130> 2019
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 130
<212> PRT
<213> Komagataella pastoris
<400> 1
Met Lys Pro Leu Ile Leu Ser Ala Ile Leu Ile Thr Leu Cys Ile Thr
1 5 10 15
Ser Ile Ala Val Ser Ala Pro Val Glu Gly Ile Phe Ala Asp Leu His
20 25 30
Asp Ser Ser His Pro Tyr Ile Thr Asp Asp Val Gly Val Arg Met Ser
35 40 45
Ala Ile Lys Glu Glu Asn Pro Asp Arg His Phe Val Gly Asp Glu Ile
50 55 60
Pro Asp Glu Ala Val Ile Gln Ser Phe Lys Ser Lys Arg Arg Glu Ile
65 70 75 80
Leu Phe Leu Leu Asp Asp Ile Gly Ser Ala Val Glu Phe Ile Gly Ser
85 90 95
Asn Leu Ala Gln Ile Glu Ala Asn His Leu Ser Glu Arg Val Gln Phe
100 105 110
Ser Trp Thr His Ile Arg Lys Asn Gln Pro Phe Gly Lys Arg Glu Ala
115 120 125
Glu Ala
130
<210> 2
<211> 390
<212> DNA
<213> Komagataella pastoris
<400> 2
atgaaaccac tcattttaag cgccatctta atcactctat gtatcacatc aattgcggtc 60
agtgcgccag tggaaggcat ttttgctgat ttacatgatt catcacatcc ttatattact 120
gatgatgtcg gtgttcgcat gtccgctatc aaagaagaaa atcctgacag acattttgtt 180
ggcgacgaaa ttcctgatga ggccgtaatc cagtcattca agtcaaaaag gagagaaatc 240
ttattccttc ttgatgatat cggatcagct gtcgagttta taggtagtaa cctagcccag 300
attgaggcta atcatttgtc ggagagagtt cagttcagtt ggacacacat taggaaaaac 360
caaccatttg gcaagagaga ggcagaagct 390
<210> 3
<211> 130
<212> PRT
<213> Komagataella pastoris
<400> 3
Met Lys Pro Leu Ile Leu Ser Ala Ile Leu Ile Thr Leu Cys Ile Thr
1 5 10 15
Ser Ile Ala Val Ser Ala Pro Val Glu Gly Ile Phe Ala Asp Leu His
20 25 30
Asp Ser Ser His Pro Tyr Ile Thr Asp Asp Val Gly Val Arg Met Ser
35 40 45
Ala Ile Lys Glu Glu Asn Pro Asp Arg His Phe Val Gly Asp Glu Ile
50 55 60
Pro Asp Glu Ala Val Ile Gln Ser Phe Lys Ser Lys Arg Arg Glu Ile
65 70 75 80
Leu Phe Leu Leu Asp Asp Ile Gly Ser Ala Val Glu Phe Ile Gly Ser
85 90 95
Asn Leu Ala Gln Ile Glu Ala Asn His Leu Ser Glu Arg Val Gln Phe
100 105 110
Asn Trp Thr His Ile Arg Lys Asn Gln Pro Phe Gly Lys Arg Glu Ala
115 120 125
Glu Ala
130
<210> 4
<211> 390
<212> DNA
<213> Komagataella pastoris
<400> 4
atgaaaccac tcattttaag cgccatctta atcactctat gtatcacatc aattgcggtc 60
agtgcgccag tggaaggcat ttttgctgat ttacatgatt catcacatcc ttatattact 120
gatgatgtcg gtgttcgcat gtccgctatc aaagaagaaa atcctgacag acattttgtt 180
ggcgacgaaa ttcctgatga ggccgtaatc cagtcattca agtcaaaaag gagagaaatc 240
ttattccttc ttgatgatat cggatcagct gtcgagttta taggtagtaa cctagcccag 300
attgaggcta atcatttgtc ggagagagtt cagttcaatt ggacacacat taggaaaaac 360
caaccatttg gcaagagaga ggcagaagct 390

Claims (5)

1. An optimized Pichia yeastKomagataella pastoris) An α -factor signal peptide characterized by: it is prepared from the Pichia yeast (SEQ ID NO: 1)Komagataella pastoris) Introducing an N into an amino acid sequence of an alpha-factor signal peptideGlycosylation sites are obtained, and the amino acid sequence is shown as SEQID NO. 3.
2. A recombinant yeast strain encoding the optimized Pichia pastoris (Pichia pastoris) (of claim 1)Komagataella pastoris) A nucleic acid for an α -factor signal peptide, wherein: the nucleic acid sequence is shown as SEQ ID NO. 4.
3. The optimized pichia pastoris (pichia pastoris) of claim 1Komagataella pastoris) Use of an alpha-factor signal peptide, characterized in that; the signal peptide is used for guiding the secretion expression of the foreign protein in pichia pastoris.
4. Use according to claim 3, characterized in that; the foreign protein is any protein.
5. A Pichia expression vector, which is characterized in that: the vector contains optimized pichia pastoris (Pichia pastoris) (A) capable of expressing the gene of claim 1Komagataella pastoris) Nucleic acid sequence of alpha-factor signal peptide.
CN201910338973.9A 2019-04-25 2019-04-25 Optimized Komagataella pastoris yeast alpha-factor signal peptide and application Active CN110028562B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910338973.9A CN110028562B (en) 2019-04-25 2019-04-25 Optimized Komagataella pastoris yeast alpha-factor signal peptide and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910338973.9A CN110028562B (en) 2019-04-25 2019-04-25 Optimized Komagataella pastoris yeast alpha-factor signal peptide and application

Publications (2)

Publication Number Publication Date
CN110028562A CN110028562A (en) 2019-07-19
CN110028562B true CN110028562B (en) 2023-03-03

Family

ID=67240183

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910338973.9A Active CN110028562B (en) 2019-04-25 2019-04-25 Optimized Komagataella pastoris yeast alpha-factor signal peptide and application

Country Status (1)

Country Link
CN (1) CN110028562B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602034A (en) * 1987-12-30 1997-02-11 Chiron Corporation Expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences
CN101538318A (en) * 2009-03-06 2009-09-23 中国人民解放军军事医学科学院生物工程研究所 Signal peptide, coding genes thereof and application

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602034A (en) * 1987-12-30 1997-02-11 Chiron Corporation Expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences
CN101538318A (en) * 2009-03-06 2009-09-23 中国人民解放军军事医学科学院生物工程研究所 Signal peptide, coding genes thereof and application

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
吴静雯.α-factor信号肽及其N-糖基化修饰对毕赤酵母外源蛋白分泌的影响.《中国优秀硕士学位论文全文数据库 基础科学辑》.2020,A006-77. *
熊爱生等.信号肽序列对毕赤酵母表达外源蛋白质的影响.《生物化学与生物物理学报》.2003,(第02期), *
石艺平等.不同信号肽对毕赤酵母表达漆酶的影响.《微生物学报》.2014,(第12期), *

Also Published As

Publication number Publication date
CN110028562A (en) 2019-07-19

Similar Documents

Publication Publication Date Title
KR102495283B1 (en) Carbon Source Controlled Protein Production in Recombinant Host Cells
KR101026526B1 (en) Method for the secretory production of heterologous protein in Escherichia coli
CN112980865A (en) Construction method of recombinant human-like collagen engineering bacteria
CN110981968B (en) Fusion protein containing rabies virus G protein, preparation method, application and vaccine thereof
CN102659928A (en) Synthetic signal peptide and application thereof
CN110054667B (en) Optimized pichia pastoris GS115 mating exohormone alpha-factor signal peptide and application thereof
CN110028562B (en) Optimized Komagataella pastoris yeast alpha-factor signal peptide and application
CN113234743A (en) Heat-resistant alpha-galactosidase gene and application thereof
WO2019184373A1 (en) Intron for increasing expression level of rhngf
Maleki et al. High expression of methylotrophic yeast-derived recombinant human erythropoietin in a pH-controlled batch system
CN101921315B (en) Artificially synthesized signal peptide and application thereof
CN103483423B (en) Artificially synthesized signal peptide and application thereof
CN113461790A (en) Leader stabilizing element for enhancing activity and expression of foreign protein in bacteria
CN110904115B (en) Canine recombinant interferon alpha 7, preparation method and application thereof, expression vector containing canine recombinant interferon alpha 7 and host cell
CN112725380A (en) High-efficiency expression system for stably expressing foreign protein CHO cell, screening method thereof and application of high-efficiency expression system in PCV2Cap protein
CN107574172B (en) Expression and purification method of anti-cancer and anti-inflammatory polypeptide Lunasin in mammalian cell CHO-S
CN108265059B (en) Recombinant dust mite 2-class allergen protein and preparation method and application thereof
CN106754393B (en) Chlamydomonas bioreactor of human epidermal growth factor and construction method and application thereof
CN106632654B (en) Optimized pIFN-gamma peptide chain and application thereof in improving yield and activity of pichia pastoris secretion expression pig IFN-gamma
CN106636123B (en) Method for constructing rhIL-12 expression system in CHO cell
WO2020072480A1 (en) Ssi cells with predictable and stable transgene expression and methods of formation
KR100798894B1 (en) Translational fusion partner for producing recombinant proteins
US20240084084A1 (en) Promoter for yeast
CN109929849B (en) Optimized pGH gene and protein and application thereof in improving yield and activity of pichia pastoris secretion expression pGH
CN111349576B (en) Pichia pastoris engineering bacteria for constitutive expression of porcine pepsinogen A and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20220615

Address after: 350000 room 1962-5, 19 / F, building 17, phase II, innovation park, 7 middle wulongjiang Avenue, high tech Zone, Fuzhou City, Fujian Province

Applicant after: Fuzhou Liangyan Technology Co.,Ltd.

Address before: 350108 science and technology office, Fujian Normal University, Minhou Town, Minhou Town, Fujian

Applicant before: Fujian Normal University

GR01 Patent grant
GR01 Patent grant